Targeting Krüppel-like factor 5 (KLF5) for cancer therapy

Current Topics in Medicinal Chemistry

Volumn 15, Issue 8, 2015, Pages 699-713

  Gao, Yu ^a   Ding, Ye ^b   Chen, Haiying ^b   Chen, Haijun ^a,b   Zhou, Jia ^b  

^a FUZHOU UNIVERSITY   (China)

^b University of Texas Medical Branch School of Medicine   (United States)

Author keywords

Cancer therapeutics; Drug discovery; KLF5 ligands; Kr ppel like factor 5 (KLF5); Signaling pathways; Transcription factors

Indexed keywords

ANDROGEN RECEPTOR; ANDROSTANOLONE; BETA CATENIN; CHEMOKINE RECEPTOR CXCR4; CYCLIN D1; EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; HIPPO PROTEIN; HISTIDINE; KRUPPEL LIKE FACTOR 5; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; NOTCH RECEPTOR; PHOSPHATIDYLINOSITOL 3 KINASE; PROGESTERONE RECEPTOR; PROTEIN KINASE C; PROTEIN P53; RAS PROTEIN; SPHINGOSINE 1 PHOSPHATE; STROMAL CELL DERIVED FACTOR 1; TRANSCRIPTION FACTOR 3; TRANSCRIPTION FACTOR CDX1; TRANSCRIPTION FACTOR FKHR; TRANSCRIPTION FACTOR SOX9; TRANSFORMING GROWTH FACTOR BETA; UBIQUITIN PROTEIN LIGASE E3; UNCLASSIFIED DRUG; UNINDEXED DRUG; WNT PROTEIN; ZINC FINGER PROTEIN; ANTINEOPLASTIC AGENT; KLF5 PROTEIN, HUMAN; KRUPPEL LIKE FACTOR;

ARTICLE; BREAST CANCER; CANCER GROWTH; CANCER THERAPY; CARCINOGENESIS; CELL PROLIFERATION; CHROMOSOME DELETION; COLORECTAL CANCER; DRUG DESIGN; ESOPHAGUS CANCER; GASTROINTESTINAL STROMAL TUMOR; GENE AMPLIFICATION; GENE MUTATION; HEAD AND NECK CANCER; HUMAN; LEUKEMIA; LUNG CANCER; ONCOGENE C MYC; ONCOGENE H RAS; ONCOGENE K RAS; OVARY CANCER; PROSTATE CANCER; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN TARGETING; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; STOMACH CANCER; TUMOR SPHEROID; WNT SIGNALING PATHWAY; ZINC FINGER MOTIF; ANTAGONISTS AND INHIBITORS; DRUG DEVELOPMENT; GENE EXPRESSION REGULATION; METABOLISM; PROTEIN CONFORMATION;

ANTINEOPLASTIC AGENTS; DRUG DISCOVERY; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; KRUPPEL-LIKE TRANSCRIPTION FACTORS; PROTEIN CONFORMATION;

EID: 84930915706     PISSN: 15680266     EISSN: 18734294     Source Type: Journal    
DOI: 10.2174/1568026615666150302105052     Document Type: Article

References (136)

1. Preiss, A.; Rosenberg, U. B.; Kienlin, A.; Seifert, E.; Jackle, H. Molecular genetics of Kruppel, a gene required for segmentation of the Drosophila embryo. Nature, 1985, 313, 27-32.
2. McConnell, B. B.; Yang, V. W. Mammalian Kruppel-like factors in health and diseases. Physiol. Rev., 2010, 90, 1337-1381.
3. Miller, I. J.; Bieker, J. J. A novel, erythroid cell-specific murine transcription factor that binds to the CACCC element and is related to the Kruppel family of nuclear proteins. Mol. Cell. Biol., 1993, 13, 2776-2786.
4. Suske, G.; Bruford, E.; Philipsen, S. Mammalian SP/KLF transcription factors: bring in the family. Genomics, 2005, 85, 551-556.
5. Jiang, J.; Chan, Y. S.; Loh, Y. H.; Cai, J.; Tong, G. Q.; Lim, C. A.; Robson, P.; Zhong, S.; Ng, H. H. A core Klf circuitry regulates selfrenewal of embryonic stem cells. Nat. Cell. Biol., 2008, 10, 353-360.
6. Mas, C.; Lussier-Price, M.; Soni, S.; Morse, T.; Arseneault, G.; Di Lello, P.; Lafrance-Vanasse, J.; Bieker, J. J.; Omichinski, J. G. Structural and functional characterization of an atypical activation domain in erythroid Kruppel-like factor (EKLF). Proc. Natl. Acad. Sci. U S A, 2011, 108, 10484-10489.
7. Tetreault, M. P.; Yang, Y.; Katz, J. P. Kruppel-like factors in cancer. Nat. Rev. Cancer, 2013, 13, 701-713.
8. Conkright, M. D.; Wani, M. A.; Anderson, K. P.; Lingrel, J. B. A gene encoding an intestinal-enriched member of the Kruppel-like factor family expressed in intestinal epithelial cells. Nucleic. Acids Res., 1999, 27, 1263-1270.
9. Dong, J. T.; Chen, C. Essential role of KLF5 transcription factor in cell proliferation and differentiation and its implications for human diseases. Cell. Mol. Life Sci., 2009, 66, 2691-2706.
10. Shindo, T.; Manabe, I.; Fukushima, Y.; Tobe, K.; Aizawa, K.; Miyamoto, S.; Kawai-Kowase, K.; Moriyama, N.; Imai, Y.; Kawakami, H.; Nishimatsu, H.; Ishikawa, T.; Suzuki, T.; Morita, H.; Maemura, K.; Sata, M.; Hirata, Y.; Komukai, M.; Kagechika, H.; Kadowaki, T.; Kurabayashi, M.; Nagai, R. Kruppel-like zincfinger transcription factor KLF5/BTEB2 is a target for angiotensin II signaling and an essential regulator of cardiovascular remodeling. Nat. Med, 2002, 8, 856-863.
11. Jang, H.; Kim, T. W.; Yoon, S.; Choi, S. Y.; Kang, T. W.; Kim, S. Y.; Kwon, Y. W.; Cho, E. J.; Youn, H. D. O-GlcNAc regulates pluripotency and reprogramming by directly acting on core components of the pluripotency network. Cell Stem Cell, 2012, 11, 62-74.
12. Ema, M.; Mori, D.; Niwa, H.; Hasegawa, Y.; Yamanaka, Y.; Hitoshi, S.; Mimura, J.; Kawabe, Y.; Hosoya, T.; Morita, M.; Shimosato, D.; Uchida, K.; Suzuki, N.; Yanagisawa, J.; Sogawa, K.; Rossant, J.; Yamamoto, M.; Takahashi, S.; Fujii-Kuriyama, Y. Kruppel-like factor 5 is essential for blastocyst development and the normal self-renewal of mouse ESCs. Cell Stem Cell, 2008, 3, 555-567.
13. Oishi, Y.; Manabe, I.; Tobe, K.; Tsushima, K.; Shindo, T.; Fujiu, K.; Nishimura, G.; Maemura, K.; Yamauchi, T.; Kubota, N.; Suzuki, R.; Kitamura, T.; Akira, S.; Kadowaki, T.; Nagai, R. Kruppel-like transcription factor KLF5 is a key regulator of adipocyte differentiation. Cell Metab., 2005, 1, 27-39.
14. Gonzalez, F. J. Getting fat: two new players in molecular adipogenesis. Cell Metab., 2005, 1, 85-86.
15. Tetreault, M. P.; Yang, Y.; Travis, J.; Yu, Q. C.; Klein-Szanto, A.; Tobias, J. W.; Katz, J. P. Esophageal squamous cell dysplasia and delayed differentiation with deletion of kruppel-like factor 4 in murine esophagus. Gastroenterology, 2010, 139, 171-181.
16. Taniguchi Ishikawa, E.; Chang, K. H.; Nayak, R.; Olsson, H. A.; Ficker, A. M.; Dunn, S. K.; Madhu, M. N.; Sengupta, A.; Whitsett, J. A.; Grimes, H. L.; Cancelas, J. A. Klf5 controls bone marrow homing of stem cells and progenitors through Rab5-mediated beta1/beta2-integrin trafficking. Nat. Commun., 2013, 4, 1660.
17. Aksoy, I.; Giudice, V.; Delahaye, E.; Wianny, F.; Aubry, M.; Mure, M.; Chen, J.; Jauch, R.; Bogu, G. K.; Nolden, T.; Himmelbauer, H.; Xavier Doss, M.; Sachinidis, A.; Schulz, H.; Hummel, O.; Martinelli, P.; Hubner, N.; Stanton, L. W.; Real, F. X.; Bourillot, P. Y.; Savatier, P. Klf4 and Klf5 differentially inhibit mesoderm and endoderm differentiation in embryonic stem cells. Nat. Commun., 2014, 5, 3719.
18. Sun, X.; Zhang, L.; Xie, H.; Wan, H.; Magella, B.; Whitsett, J. A.; Dey, S. K. Kruppel-like factor 5 (KLF5) is critical for conferring uterine receptivity to implantation. Proc. Natl. Acad. Sci. USA, 2012, 109, 1145-1150.
19. Yang, X. O.; Doty, R. T.; Hicks, J. S.; Willerford, D. M. Regulation of T-cell receptor D beta 1 promoter by KLF5 through reiterated GC-rich motifs. Blood, 2003, 101, 4492-4499.
20. Hoshino, Y.; Kurabayashi, M.; Kanda, T.; Hasegawa, A.; Sakamoto, H.; Okamoto, E.; Kowase, K.; Watanabe, N.; Manabe, I.; Suzuki, T.; Nakano, A.; Takase, S.; Wilcox, J. N.; Nagai, R. Regulated expression of the BTEB2 transcription factor in vascular smooth muscle cells: analysis of developmental and pathological expression profiles shows implications as a predictive factor for restenosis. Circulation, 2000, 102, 2528-2534.
21. Watanabe, N.; Kurabayashi, M.; Shimomura, Y.; Kawai-Kowase, K.; Hoshino, Y.; Manabe, I.; Watanabe, M.; Aikawa, M.; Kuro-o, M.; Suzuki, T.; Yazaki, Y.; Nagai, R. BTEB2, a Kruppel-like transcription factor, regulates expression of the SMemb/Nonmuscle myosin heavy chain B (SMemb/NMHC-B) gene. Circ. Res., 1999, 85, 182-191.
22. Diakiw, S. M.; D'Andrea, R. J.; Brown, A. L. The double life of KLF5: Opposing roles in regulation of gene-expression, cellular function, and transformation. IUBMB Life, 2013, 65, 999-1011.
23. Lin, S.; Wang, D.; Iyer, S.; Ghaleb, A. M.; Shim, H.; Yang, V. W.; Chun, J.; Yun, C. C. The absence of LPA2 attenuates tumor formation in an experimental model of colitis-associated cancer. Gastroenterology, 2009, 136, 1711-1720.
24. Ghaleb, A. M.; Nandan, M. O.; Chanchevalap, S.; Dalton, W. B.; Hisamuddin, I. M.; Yang, V. W. Kruppel-like factors 4 and 5: the yin and yang regulators of cellular proliferation. Cell Res., 2005, 15, 92-96.
25. Luan, Y.; Wang, P. FBW7-mediated ubiquitination and degradation of KLF5. World J. Biol. Chem., 2014, 5, 216-223.
26. Oishi, Y.; Manabe, I.; Tobe, K.; Ohsugi, M.; Kubota, T.; Fujiu, K.; Maemura, K.; Kubota, N.; Kadowaki, T.; Nagai, R. SUMOylation of Kruppel-like transcription factor 5 acts as a molecular switch in transcriptional programs of lipid metabolism involving PPARdelta. Nat. Med., 2008, 14, 656-666.
27. Davis, H.; Lewis, A.; Behrens, A.; Tomlinson, I. Investigation of the atypical FBXW7 mutation spectrum in human tumours by conditional expression of a heterozygous propellor tip missense allele in the mouse intestines. Gut., 2014, 63, 792-799.
28. Brayer, K. J.; Segal, D. J. Keep your fingers off my DNA: proteinprotein interactions mediated by C2H2 zinc finger domains. Cell Biochem. Biophys., 2008, 50, 111-131.
29. Kaczynski, J.; Cook, T.; Urrutia, R. Sp1-and Kruppel-like transcription factors. Genome Biol., 2003, 4, 206.
30. Dang, D. T.; Pevsner, J.; Yang, V. W. The biology of the mammalian Kruppel-like family of transcription factors. Int J Biochem. Cell. Biol., 2000, 32, 1103-1121.
31. Schuetz, A.; Nana, D.; Rose, C.; Zocher, G.; Milanovic, M.; Koenigsmann, J.; Blasig, R.; Heinemann, U.; Carstanjen, D. The structure of the Klf4 DNA-binding domain links to self-renewal and macrophage differentiation. Cell. Mol. Life Sci., 2011, 68, 3121-3131.
32. Liu, Y.; Olanrewaju, Y. O.; Zheng, Y.; Hashimoto, H.; Blumenthal, R. M.; Zhang, X.; Cheng, X. Structural basis for Klf4 recognition of methylated DNA. Nucleic. Acids. Res., 2014, 42, 4859-4867.
33. Taneyhill, L.; Pennica, D. Identification of Wnt responsive genes using a murine mammary epithelial cell line model system. BMC Dev. Biol., 2004, 4, 6.
34. Ziemer, L. T.; Pennica, D.; Levine, A. J. Identification of a mouse homolog of the human BTEB2 transcription factor as a betacatenin-independent Wnt-1-responsive gene. Mol. Cell Biol., 2001, 21, 562-574.
35. McConnell, B. B.; Kim, S. S.; Yu, K.; Ghaleb, A. M.; Takeda, N.; Manabe, I.; Nusrat, A.; Nagai, R.; Yang, V. W. Kruppel-like factor 5 is important for maintenance of crypt architecture and barrier function in mouse intestine. Gastroenterology, 2011, 141, 1302-1313.
36. McConnell, B. B.; Bialkowska, A. B.; Nandan, M. O.; Ghaleb, A. M.; Gordon, F. J.; Yang, V. W. Haploinsufficiency of Kruppel-like factor 5 rescues the tumor-initiating effect of the Apc(Min) mutation in the intestine. Cancer Res., 2009, 69, 4125-4133.
37. Gyorffy, B.; Schafer, R. Biomarkers downstream of RAS: a search for robust transcriptional targets. Curr. Cancer Drug Targets, 2010, 10, 858-868.
38. Yang, Y.; Goldstein, B. G.; Nakagawa, H.; Katz, J. P. Kruppel-like factor 5 activates MEK/ERK signaling via EGFR in primary squamous epithelial cells. FASEB J., 2007, 21, 543-550.
39. Chen, C.; Benjamin, M. S.; Sun, X.; Otto, K. B.; Guo, P.; Dong, X. Y.; Bao, Y.; Zhou, Z.; Cheng, X.; Simons, J. W.; Dong, J. T. KLF5 promotes cell proliferation and tumorigenesis through gene regulation and the TSU-Pr1 human bladder cancer cell line. Int. J. Cancer, 2006, 118, 1346-1355.
40. Nandan, M. O.; Yoon, H. S.; Zhao, W.; Ouko, L. A.; Chanchevalap, S.; Yang, V. W. Kruppel-like factor 5 mediates the transforming activity of oncogenic H-Ras. Oncogene, 2004, 23, 3404-3413.
41. Nandan, M. O.; McConnell, B. B.; Ghaleb, A. M.; Bialkowska, A. B.; Sheng, H.; Shao, J.; Babbin, B. A.; Robine, S.; Yang, V. W. Kruppel-like factor 5 mediates cellular transformation during oncogenic KRAS-induced intestinal tumorigenesis. Gastroenterology, 2008, 134, 120-130.
42. Usui, S.; Sugimoto, N.; Takuwa, N.; Sakagami, S.; Takata, S.; Kaneko, S.; Takuwa, Y. Blood lipid mediator sphingosine 1-phosphate potently stimulates platelet-derived growth factor-A and-B chain expression through S1P1-Gi-Ras-MAPK-dependent induction of Kruppel-like factor 5. J. Biol. Chem., 2004, 279, 12300-12311.
43. Liu, R.; Zhou, Z.; Zhao, D.; Chen, C. The induction of KLF5 transcription factor by progesterone contributes to progesteroneinduced breast cancer cell proliferation and dedifferentiation. Mol. Endocrinol, 2011, 25, 1137-1144.
44. Chen, C.; Zhou, Y.; Zhou, Z.; Sun, X.; Otto, K. B.; Uht, R. M.; Dong, J. T. Regulation of KLF5 involves the Sp1 transcription factor in human epithelial cells. Gene, 2004, 330, 133-142.
45. Frigo, D. E.; Sherk, A. B.; Wittmann, B. M.; Norris, J. D.; Wang, Q.; Joseph, J. D.; Toner, A. P.; Brown, M.; McDonnell, D. P. Induction of Kruppel-like factor 5 expression by androgens results in increased CXCR4-dependent migration of prostate cancer cells in vitro. Mol. Endocrinol, 2009, 23, 1385-1396.
46. Lee, M. Y.; Moon, J. S.; Park, S. W.; Koh, Y. K.; Ahn, Y. H.; Kim, K. S. KLF5 enhances SREBP-1 action in androgen-dependent induction of fatty acid synthase in prostate cancer cells. Biochem. J., 2009, 417, 313-322.
47. Takagi, K.; Miki, Y.; Onodera, Y.; Nakamura, Y.; Ishida, T.; Watanabe, M.; Inoue, S.; Sasano, H.; Suzuki, T. Kruppel-like factor 5 in human breast carcinoma: a potent prognostic factor induced by androgens. Endocr. Relat. Cancer, 2012, 19, 741-750.
48. Zhao, K. W.; Sikriwal, D.; Dong, X.; Guo, P.; Sun, X.; Dong, J. T. Oestrogen causes degradation of KLF5 by inducing the E3 ubiquitin ligase EFP in ER-positive breast cancer cells. Biochem. J., 2011, 437, 323-333.
49. Nakajima, Y.; Akaogi, K.; Suzuki, T.; Osakabe, A.; Yamaguchi, C.; Sunahara, N.; Ishida, J.; Kako, K.; Ogawa, S.; Fujimura, T.; Homma, Y.; Fukamizu, A.; Murayama, A.; Kimura, K.; Inoue, S.; Yanagisawa, J. Estrogen regulates tumor growth through a nonclassical pathway that includes the transcription factors ERbeta and KLF5. Sci. Signal, 2011, 4, ra22.
50. Guo, P.; Dong, X. Y.; Zhao, K. W.; Sun, X.; Li, Q.; Dong, J. T. Estrogen-induced interaction between KLF5 and estrogen receptor (ER) suppresses the function of ER in ER-positive breast cancer cells. Int. J. Cancer, 2010, 126, 81-89.
51. Guo, P.; Dong, X. Y.; Zhang, X.; Zhao, K. W.; Sun, X.; Li, Q.; Dong, J. T. Pro-proliferative factor KLF5 becomes anti-proliferative in epithelial homeostasis upon signaling-mediated modification. J. Biol. Chem, 2009, 284, 6071-6078.
52. Guo, P.; Zhao, K. W.; Dong, X. Y.; Sun, X.; Dong, J. T. Acetylation of KLF5 alters the assembly of p15 transcription factors in transforming growth factor-beta-mediated induction in epithelial cells. J. Biol. Chem., 2009, 284, 18184-18193.
53. Guo, P.; Dong, X. Y.; Zhao, K.; Sun, X.; Li, Q.; Dong, J. T. Opposing effects of KLF5 on the transcription of MYC in epithelial proliferation in the context of transforming growth factor beta. J. Biol. Chem, 2009, 284, 28243-28252.
54. Nagai, R.; Suzuki, T.; Aizawa, K.; Shindo, T.; Manabe, I. Significance of the transcription factor KLF5 in cardiovascular remodeling. J. Thromb. Haemost., 2005, 3, 1569-1576.
55. Kada, N.; Suzuki, T.; Aizawa, K.; Munemasa, Y.; Matsumura, T.; Sawaki, D.; Nagai, R. Acyclic retinoid inhibits functional interaction of transcription factors Kruppel-like factor 5 and retinoic acid receptor-alpha. FEBS Lett., 2008, 582, 1755-1760.
56. Fujiu, K.; Manabe, I.; Ishihara, A.; Oishi, Y.; Iwata, H.; Nishimura, G.; Shindo, T.; Maemura, K.; Kagechika, H.; Shudo, K.; Nagai, R. Synthetic retinoid Am80 suppresses smooth muscle phenotypic modulation and in-stent neointima formation by inhibiting KLF5. Circ. Res., 2005, 97, 1132-1141.
57. Pislaru, S.; Simari, R. D. The translation of transcription. Circ. Res., 2005, 97, 1083-1084.
58. Zhang, X. H.; Zheng, B.; Han, M.; Miao, S. B.; Wen, J. K. Synthetic retinoid Am80 inhibits interaction of KLF5 with RAR alpha through inducing KLF5 dephosphorylation mediated by the PI3K/Akt signaling in vascular smooth muscle cells. FEBS Lett., 2009, 583, 1231-1236.
59. Lv, X. R.; Zheng, B.; Li, S. Y.; Han, A. L.; Wang, C.; Shi, J. H.; Zhang, X. H.; Liu, Y.; Li, Y. H.; Wen, J. K. Synthetic retinoid Am80 up-regulates apelin expression by promoting interaction of RARalpha with KLF5 and Sp1 in vascular smooth muscle cells. Biochem. J., 2013, 456, 35-46.
60. Zheng, B.; Han, M.; Shu, Y. N.; Li, Y. J.; Miao, S. B.; Zhang, X. H.; Shi, H. J.; Zhang, T.; Wen, J. K. HDAC2 phosphorylationdependent Klf5 deacetylation and RARalpha acetylation induced by RAR agonist switch the transcription regulatory programs of p21 in VSMCs. Cell Res., 2011, 21, 1487-1508.
61. Zhi, X.; Zhao, D.; Zhou, Z.; Liu, R.; Chen, C. YAP promotes breast cell proliferation and survival partially through stabilizing the KLF5 transcription factor. Am. J. Pathol., 2012, 180, 2452-2461.
62. Gao, Y.; Shi, Q.; Xu, S.; Du, C.; Liang, L.; Wu, K.; Wang, K.; Wang, X.; Chang, L. S.; He, D.; Guo, P. Curcumin Promotes KLF5 Proteasome Degradation through Downregulating YAP/TAZ in Bladder Cancer Cells. Int. J. Mol. Sci., 2014, 15, 15173-15187.
63. Yang, Y.; Nakagawa, H.; Tetreault, M. P.; Billig, J.; Victor, N.; Goyal, A.; Sepulveda, A. R.; Katz, J. P. Loss of transcription factor KLF5 in the context of p53 ablation drives invasive progression of human squamous cell cancer. Cancer Res., 2011, 71, 6475-6484.
64. Zhang, Y.; Lam, O.; Nguyen, M. T.; Ng, G.; Pear, W. S.; Ai, W.; Wang, I. J.; Kao, W. W.; Liu, C. Y. Mastermind-like transcriptional co-activator-mediated Notch signaling is indispensable for maintaining conjunctival epithelial identity. Development, 2013, 140, 594-605.
65. McConnell, B. B.; Ghaleb, A. M.; Nandan, M. O.; Yang, V. W. The diverse functions of Kruppel-like factors 4 and 5 in epithelial biology and pathobiology. Bioessays, 2007, 29, 549-557.
66. Ohnishi, S.; Laub, F.; Matsumoto, N.; Asaka, M.; Ramirez, F.; Yoshida, T.; Terada, M. Developmental expression of the mouse gene coding for the Kruppel-like transcription factor KLF5. Dev. Dyn., 2000, 217, 421-429.
67. McConnell, B. B.; Klapproth, J. M.; Sasaki, M.; Nandan, M. O.; Yang, V. W. Kruppel-like factor 5 mediates transmissible murine colonic hyperplasia caused by Citrobacter rodentium infection. Gastroenterology, 2008, 134, 1007-1016.
68. McConnell, B. B.; Kim, S. S.; Bialkowska, A. B.; Yu, K.; Sitaraman, S. V.; Yang, V. W. Kruppel-like factor 5 protects against dextran sulfate sodium-induced colonic injury in mice by promoting epithelial repair. Gastroenterology, 2011, 140, 540-549.
69. Tetreault, M. P.; Alrabaa, R.; McGeehan, M.; Katz, J. P. Kruppellike factor 5 protects against murine colitis and activates JAKSTAT signaling in vivo. PLoS One, 2012, 7, e38338.
70. Chanchevalap, S.; Nandan, M. O.; Merlin, D.; Yang, V. W. All-trans retinoic acid inhibits proliferation of intestinal epithelial cells by inhibiting expression of the gene encoding Kruppel-like factor 5. FEBS Lett., 2004, 578, 99-105.
71. Zhang, H.; Bialkowska, A.; Rusovici, R.; Chanchevalap, S.; Shim, H.; Katz, J. P.; Yang, V. W.; Yun, C. C. Lysophosphatidic acid facilitates proliferation of colon cancer cells via induction of Kruppel-like factor 5. J. Biol. Chem., 2007, 282, 15541-15549.
72. Nandan, M. O.; Ghaleb, A. M.; Liu, Y.; Bialkowska, A. B.; McConnell, B. B.; Shroyer, K. R.; Robine, S.; Yang, V. W. Inducible intestine-specific deletion of Kruppel-like factor 5 is characterized by a regenerative response in adult mouse colon. Dev. Biol., 2014, 387, 191-202.
73. Nakaya, T.; Ogawa, S.; Manabe, I.; Tanaka, M.; Sanada, M.; Sato, T.; Taketo, M. M.; Nakao, K.; Clevers, H.; Fukayama, M.; Kuroda, M.; Nagai, R. KLF5 regulates the integrity and oncogenicity of intestinal stem cells. Cancer Res., 2014, 74, 2882-2891.
74. Ghaleb, A. M.; Yang, V. W. The Pathobiology of Kruppel-like Factors in Colorectal Cancer. Curr. Colorectal Cancer Rep., 2008, 4, 59-64.
75. Dardousis, K.; Voolstra, C.; Roengvoraphoj, M.; Sekandarzad, A.; Mesghenna, S.; Winkler, J.; Ko, Y.; Hescheler, J.; Sachinidis, A. Identification of differentially expressed genes involved in the formation of multicellular tumor spheroids by HT-29 colon carcinoma cells. Mol. Ther., 2007, 15, 94-102.
76. Segditsas, S.; Tomlinson, I. Colorectal cancer and genetic alterations in the Wnt pathway. Oncogene, 2006, 25, 7531-7537.
77. Poulogiannis, G.; Luo, F.; Arends, M. J. RAS signalling in the colorectum in health and disease. Cell Commun. Adhes., 2012, 19, 1-9.
78. Nandan, M. O.; Ghaleb, A. M.; McConnell, B. B.; Patel, N. V.; Robine, S.; Yang, V. W. Kruppel-like factor 5 is a crucial mediator of intestinal tumorigenesis in mice harboring combined ApcMin and KRASV12 mutations. Mol. Cancer, 2010, 9, 63.
79. Pagliuca, A.; Valvo, C.; Fabrizi, E.; di Martino, S.; Biffoni, M.; Runci, D.; Forte, S.; De Maria, R.; Ricci-Vitiani, L. Analysis of the combined action of miR-143 and miR-145 on oncogenic pathways in colorectal cancer cells reveals a coordinate program of gene repression. Oncogene, 2013, 32, 4806-4813.
80. Bialkowska, A. B.; Liu, Y.; Nandan, M. O.; Yang, V. W. A colon cancer-derived mutant of Kruppel-like factor 5 (KLF5) is resistant to degradation by glycogen synthase kinase 3beta (GSK3beta) and the E3 ubiquitin ligase F-box and WD repeat domain-containing 7alpha (FBW7alpha). J. Biol. Chem, 2014, 289, 5997-6005.
81. Bateman, N. W.; Tan, D.; Pestell, R. G.; Black, J. D.; Black, A. R. Intestinal tumor progression is associated with altered function of KLF5. J. Biol. Chem., 2004, 279, 12093-12101.
82. Lee, S. J.; No, Y. R.; Dang, D. T.; Dang, L. H.; Yang, V. W.; Shim, H.; Yun, C. C. Regulation of hypoxia-inducible factor 1alpha (HIF-1alpha) by lysophosphatidic acid is dependent on interplay between p53 and Kruppel-like factor 5. J. Biol. Chem., 2013, 288, 25244-25253.
83. Edlund, K.; Larsson, O.; Ameur, A.; Bunikis, I.; Gyllensten, U.; Leroy, B.; Sundstrom, M.; Micke, P.; Botling, J.; Soussi, T. Datadriven unbiased curation of the TP53 tumor suppressor gene mutation database and validation by ultradeep sequencing of human tumors. Proc. Natl. Acad. Sci. USA, 2012, 109, 9551-9556.
84. Solomon, H.; Brosh, R.; Buganim, Y.; Rotter, V. Inactivation of the p53 tumor suppressor gene and activation of the Ras oncogene: cooperative events in tumorigenesis. Discov. Med., 2010, 9, 448-454.
85. Liu, R.; Dong, J. T.; Chen, C. Role of KLF5 in hormonal signaling and breast cancer development. Vitam. Horm., 2013, 93, 213-225.
86. Chen, C.; Bhalala, H. V.; Qiao, H.; Dong, J. T. A possible tumor suppressor role of the KLF5 transcription factor in human breast cancer. Oncogene, 2002, 21, 6567-6572.
87. Chen, C. J.; Lin, S. E.; Lin, Y. M.; Lin, S. H.; Chen, D. R.; Chen, C. L. Association of expression of kruppel-like factor 4 and kruppel-like factor 5 with the clinical manifestations of breast cancer. Pathol. Oncol. Res., 2012, 18, 161-168.
88. Tong, D.; Czerwenka, K.; Heinze, G.; Ryffel, M.; Schuster, E.; Witt, A.; Leodolter, S.; Zeillinger, R. Expression of KLF5 is a prognostic factor for disease-free survival and overall survival in patients with breast cancer. Clin. Cancer Res., 2006, 12, 2442-2448.
89. Zhao, D.; Zhi, X.; Zhou, Z.; Chen, C. TAZ antagonizes the WWP1-mediated KLF5 degradation and promotes breast cell proliferation and tumorigenesis. Carcinogenesis, 2012, 33, 59-67.
90. Zheng, H. Q.; Zhou, Z.; Huang, J.; Chaudhury, L.; Dong, J. T.; Chen, C. Kruppel-like factor 5 promotes breast cell proliferation partially through upregulating the transcription of fibroblast growth factor binding protein 1. Oncogene, 2009, 28, 3702-3713.
91. Liu, R.; Zheng, H. Q.; Zhou, Z.; Dong, J. T.; Chen, C. KLF5 promotes breast cell survival partially through fibroblast growth factor-binding protein 1-pERK-mediated dual specificity MKP-1 protein phosphorylation and stabilization. J. Biol. Chem., 2009, 284, 16791-16798.
92. Zhao, D.; Zheng, H. Q.; Zhou, Z.; Chen, C. The Fbw7 tumor suppressor targets KLF5 for ubiquitin-mediated degradation and suppresses breast cell proliferation. Cancer Res., 2010, 70, 4728-4738.
93. Liu, N.; Li, H.; Li, S.; Shen, M.; Xiao, N.; Chen, Y.; Wang, Y.; Wang, W.; Wang, R.; Wang, Q.; Sun, J.; Wang, P. The Fbw7/human CDC4 tumor suppressor targets proproliferative factor KLF5 for ubiquitination and degradation through multiple phosphodegron motifs. J. Biol. Chem., 2010, 285, 18858-18867.
94. Xia, H.; Wang, C.; Chen, W.; Zhang, H.; Chaudhury, L.; Zhou, Z.; Liu, R.; Chen, C. Kruppel-like factor 5 transcription factor promotes microsomal prostaglandin E2 synthase 1 gene transcription in breast cancer. J. Biol. Chem., 2013, 288, 26731-26740.
95. Dong, J. T. Chromosomal deletions and tumor suppressor genes in prostate cancer. Cancer Metastasis Rev., 2001, 20, 173-193.
96. Dong, J. T.; Chen, C.; Stultz, B. G.; Isaacs, J. T.; Frierson, H. F., Jr. Deletion at 13q21 is associated with aggressive prostate cancers. Cancer Res., 2000, 60, 3880-3883.
97. Chen, C.; Bhalala, H. V.; Vessella, R. L.; Dong, J. T. KLF5 is frequently deleted and down-regulated but rarely mutated in prostate cancer. Prostate, 2003, 55, 81-88.
98. Chen, C.; Sun, X.; Ran, Q.; Wilkinson, K. D.; Murphy, T. J.; Simons, J. W.; Dong, J. T. Ubiquitin-proteasome degradation of KLF5 transcription factor in cancer and untransformed epithelial cells. Oncogene, 2005, 24, 3319-3327.
99. Chen, C.; Sun, X.; Guo, P.; Dong, X. Y.; Sethi, P.; Cheng, X.; Zhou, J.; Ling, J.; Simons, J. W.; Lingrel, J. B.; Dong, J. T. Human Kruppel-like factor 5 is a target of the E3 ubiquitin ligase WWP1 for proteolysis in epithelial cells. J. Biol. Chem., 2005, 280, 41553-41561.
100. Xing, C.; Fu, X.; Sun, X.; Guo, P.; Li, M.; Dong, J. T. Different expression patterns and functions of acetylated and unacetylated Klf5 in the proliferation and differentiation of prostatic epithelial cells. PLoS One, 2013, 8, e65538.
101. Li, X.; Zhang, B.; Wu, Q.; Ci, X.; Zhao, R.; Zhang, Z.; Xia, S.; Su, D.; Chen, J.; Ma, G.; Fu, L.; Dong, J. T. Interruption of KLF5 acetylation converts its function from tumor suppressor to tumor promoter in prostate cancer cells. Int. J. Cancer, 2015, 136, 536-546.
102. Yagi, N.; Manabe, I.; Tottori, T.; Ishihara, A.; Ogata, F.; Kim, J. H.; Nishimura, S.; Fujiu, K.; Oishi, Y.; Itaka, K.; Kato, Y.; Yamauchi, M.; Nagai, R. A nanoparticle system specifically designed to deliver short interfering RNA inhibits tumor growth in vivo. Cancer Res., 2009, 69, 6531-6538.
103. Kwak, M. K.; Lee, H. J.; Hur, K.; Park do, J.; Lee, H. S.; Kim, W. H.; Lee, K. U.; Choe, K. J.; Guilford, P.; Yang, H. K. Expression of Kruppel-like factor 5 in human gastric carcinomas. J. Cancer Res. Clin. Oncol., 2008, 134, 163-167.
104. Soon, M. S.; Hsu, L. S.; Chen, C. J.; Chu, P. Y.; Liou, J. H.; Lin, S. H.; Hsu, J. D.; Yeh, K. T. Expression of Kruppel-like factor 5 in gastric cancer and its clinical correlation in Taiwan. Virchows Arch., 2011, 459, 161-166.
105. Deng, N.; Goh, L. K.; Wang, H.; Das, K.; Tao, J.; Tan, I. B.; Zhang, S.; Lee, M.; Wu, J.; Lim, K. H.; Lei, Z.; Goh, G.; Lim, Q. Y.; Tan, A. L.; Sin Poh, D. Y.; Riahi, S.; Bell, S.; Shi, M. M.; Linnartz, R.; Zhu, F.; Yeoh, K. G.; Toh, H. C.; Yong, W. P.; Cheong, H. C.; Rha, S. Y.; Boussioutas, A.; Grabsch, H.; Rozen, S.; Tan, P. A comprehensive survey of genomic alterations in gastric cancer reveals systematic patterns of molecular exclusivity and cooccurrence among distinct therapeutic targets. Gut, 2012, 61, 673-684.
106. Akhavan-Niaki, H.; Samadani, A. A. Molecular insight in gastric cancer induction: an overview of cancer stemness genes. Cell Biochem. Biophys., 2014, 68, 463-473.
107. Fujii, Y.; Yoshihashi, K.; Suzuki, H.; Tsutsumi, S.; Mutoh, H.; Maeda, S.; Yamagata, Y.; Seto, Y.; Aburatani, H.; Hatakeyama, M. CDX1 confers intestinal phenotype on gastric epithelial cells via induction of stemness-associated reprogramming factors SALL4 and KLF5. Proc. Natl. Acad. Sci. USA, 2012, 109, 20584-20589.
108. Noto, J. M.; Peek, R. M., Jr. Gastric-to-intestinal transdifferentiation and cancer. Proc. Natl. Acad. Sci. USA, 2012, 109, 20173-20174.
109. Noto, J. M.; Khizanishvili, T.; Chaturvedi, R.; Piazuelo, M. B.; Romero-Gallo, J.; Delgado, A. G.; Khurana, S. S.; Sierra, J. C.; Krishna, U. S.; Suarez, G.; Powell, A. E.; Goldenring, J. R.; Coffey, R. J.; Yang, V. W.; Correa, P.; Mills, J. C.; Wilson, K. T.; Peek, R. M., Jr. Helicobacter pylori promotes the expression of Kruppellike factor 5, a mediator of carcinogenesis, in vitro and in vivo. PLoS One, 2013, 8, e54344.
110. Chia, N. Y.; Deng, N.; Das, K.; Huang, D.; Hu, L.; Zhu, Y.; Lim, K. H.; Lee, M. H.; Wu, J.; Sam, X. X.; Tan, G. S.; Wan, W. K.; Yu, W.; Gan, A.; Tan, A. L.; Tay, S. T.; Soo, K. C.; Wong, W. K.; Dominguez, L. T.; Ng, H. H.; Rozen, S.; Goh, L. K.; Teh, B. T.; Tan, P. Regulatory crosstalk between lineage-survival oncogenes KLF5, GATA4 and GATA6 cooperatively promotes gastric cancer development. Gut, 2015, DOI: 10. 1136/gutjnl-2013-306596.
111. Wan, H.; Luo, F.; Wert, S. E.; Zhang, L.; Xu, Y.; Ikegami, M.; Maeda, Y.; Bell, S. M.; Whitsett, J. A. Kruppel-like factor 5 is required for perinatal lung morphogenesis and function. Development, 2008, 135, 2563-2572.
112. Courboulin, A.; Tremblay, V. L.; Barrier, M.; Meloche, J.; Jacob, M. H.; Chapolard, M.; Bisserier, M.; Paulin, R.; Lambert, C.; Provencher, S.; Bonnet, S. Kruppel-like factor 5 contributes to pulmonary artery smooth muscle proliferation and resistance to apoptosis in human pulmonary arterial hypertension. Respir. Res., 2011, 12, 128.
113. Li, Q.; Dong, Z.; Zhou, F.; Cai, X.; Gao, Y.; Wang, L. W. Kruppel-Like Factor 5 Promotes Lung Tumorigenesis through Upregulation of Sox4. Cell Physiol. Biochem., 2014, 33, 1-10.
114. Li, X.; Liu, X.; Xu, Y.; Liu, J.; Xie, M.; Ni, W.; Chen, S. KLF5 promotes hypoxia-induced survival and inhibits apoptosis in nonsmall cell lung cancer cells via HIF-1alpha. Int. J. Oncol., 2014, 45, 1507-1514.
115. Shimamura, T.; Imoto, S.; Shimada, Y.; Hosono, Y.; Niida, A.; Nagasaki, M.; Yamaguchi, R.; Takahashi, T.; Miyano, S. A novel network profiling analysis reveals system changes in epithelialmesenchymal transition. PLoS One, 2011, 6, e20804.
116. Meyer, S. E.; Hasenstein, J. R.; Baktula, A.; Velu, C. S.; Xu, Y.; Wan, H.; Whitsett, J. A.; Gilks, C. B.; Grimes, H. L. Kruppel-like factor 5 is not required for K-RasG12D lung tumorigenesis, but represses ABCG2 expression and is associated with better diseasespecific survival. Am. J. Pathol, 2010, 177, 1503-1513.
117. Humbert, M.; Halter, V.; Shan, D.; Laedrach, J.; Leibundgut, E. O.; Baerlocher, G. M.; Tobler, A.; Fey, M. F.; Tschan, M. P. Deregulated expression of Kruppel-like factors in acute myeloid leukemia. Leuk. Res., 2011, 35, 909-913.
118. Diakiw, S. M.; Kok, C. H.; To, L. B.; Lewis, I. D.; Brown, A. L.; D'Andrea, R. J. The granulocyte-associated transcription factor Kruppel-like factor 5 is silenced by hypermethylation in acute myeloid leukemia. Leuk. Res., 2012, 36, 110-116.
119. Diakiw, S. M.; Perugini, M.; Kok, C. H.; Engler, G. A.; Cummings, N.; To, L. B.; Wei, A. H.; Lewis, I. D.; Brown, A. L.; D'Andrea, R. J. Methylation of KLF5 contributes to reduced expression in acute myeloid leukaemia and is associated with poor overall survival. Br. J. Haematol., 2013, 161, 884-888.
120. Federzoni, E. A.; Humbert, M.; Torbett, B. E.; Behre, G.; Fey, M. F.; Tschan, M. P. CEBPA-dependent HK3 and KLF5 expression in primary AML and during AML differentiation. Sci. Rep., 2014, 4, 4261.
121. Zhu, N.; Gu, L.; Findley, H. W.; Chen, C.; Dong, J. T.; Yang, L.; Zhou, M. KLF5 Interacts with p53 in regulating survivin expression in acute lymphoblastic leukemia. J. Biol. Chem., 2006, 281, 14711-14718.
122. Bell, S. M.; Zhang, L.; Mendell, A.; Xu, Y.; Haitchi, H. M.; Lessard, J. L.; Whitsett, J. A. Kruppel-like factor 5 is required for formation and differentiation of the bladder urothelium. Dev. Biol., 2011, 358, 79-90.
123. Ohnishi, S.; Ohnami, S.; Laub, F.; Aoki, K.; Suzuki, K.; Kanai, Y.; Haga, K.; Asaka, M.; Ramirez, F.; Yoshida, T. Downregulation and growth inhibitory effect of epithelial-type Kruppel-like transcription factor KLF4, but not KLF5, in bladder cancer. Biochem. Biophys. Res. Commun., 2003, 308, 251-256.
124. Goldstein, B. G.; Chao, H. H.; Yang, Y.; Yermolina, Y. A.; Tobias, J. W.; Katz, J. P. Overexpression of Kruppel-like factor 5 in esophageal epithelia in vivo leads to increased proliferation in basal but not suprabasal cells. Am. J. Physiol. Gastrointest Liver Physiol., 2007, 292, G1784-1792.
125. Yang, Y.; Goldstein, B. G.; Chao, H. H.; Katz, J. P. KLF4 and KLF5 regulate proliferation, apoptosis and invasion in esophageal cancer cells. Cancer Biol. Ther., 2005, 4, 1216-1221.
126. Mao, X.; Miao, S.; He, H.; Pei, R.; Yang, X.; Xiu, C.; Song, K.; Zhang, J.; Sun, J.; Jia, S.; Guan, Q. Kruppel-like factor 5: a novel biomarker for lymph node metastasis and recurrence in supraglottic squamous cell laryngeal carcinoma. Tumour Biol., 2014, 35, 623-629.
127. Dong, Z.; Yang, L.; Lai, D. KLF5 strengthens drug resistance of ovarian cancer stem-like cells by regulating survivin expression. Cell Prolif., 2013, 46, 425-435.
128. Zhou, W.; Zeng, X.; Liu, T. Aberrations of chromosome 13q in gastrointestinal stromal tumors: analysis of 91 cases by fluorescence in situ hybridization (FISH). Diagn. Mol. Pathol., 2009, 18, 72-80.
129. Kagechika, H.; Kawachi, E.; Hashimoto, Y.; Himi, T.; Shudo, K. Retinobenzoic acids. 1. Structure-activity relationships of aromatic amides with retinoidal activity. J. Med. Chem., 1988, 31, 2182-2192.
130. Kagechika, H.; Shudo, K. Synthetic retinoids: recent developments concerning structure and clinical utility. J. Med. Chem., 2005, 48, 5875-5883.
131. Shin, J.; Carr, A.; Corner, G. A.; Togel, L.; Davaos-Salas, M.; Tran, H.; Chueh, A. C.; Al-Obaidi, S.; Chionh, F.; Ahmed, N.; Buchanan, D. D.; Young, J. P.; Malo, M. S.; Hodin, R. A.; Arango, D.; Sieber, O. M.; Augenlicht, L. H.; Dhillon, A. S.; Weber, T. K.; Mariadason, J. M. The intestinal epithelial cell differentiation marker intestinal alkaline phosphatase (ALPi) is selectively induced by histone deacetylase inhibitors (HDACi) in colon cancer cells in a Kruppellike factor 5 (KLF5)-dependent manner. J. Biol. Chem., 2014, 289, 25306-25316.
132. Bialkowska, A. B.; Du, Y.; Fu, H.; Yang, V. W. Identification of novel small-molecule compounds that inhibit the proproliferative Kruppel-like factor 5 in colorectal cancer cells by high-throughput screening. Mol. Cancer. Ther., 2009, 8, 563-570.
133. Chen, H.; Zhou, X.; Wang, A.; Zheng, Y.; Gao, Y.; Zhou, J. Evolutions in fragment-based drug design: the deconstructionreconstruction approach. Drug Discov. Today, 2015, 20, 105-113.
134. Bialkowska, A. B.; Crisp, M.; Bannister, T.; He, Y.; Chowdhury, S.; Schurer, S.; Chase, P.; Spicer, T.; Madoux, F.; Tian, C.; Hodder, P.; Zaharevitz, D.; Yang, V. W. Identification of small-molecule inhibitors of the colorectal cancer oncogene Kruppel-like factor 5 expression by ultrahigh-throughput screening. Mol. Cancer Ther., 2011, 10, 2043-2051.
135. Kawai-Kowase, K.; Kurabayashi, M.; Hoshino, Y.; Ohyama, Y.; Nagai, R. Transcriptional activation of the zinc finger transcription factor BTEB2 gene by Egr-1 through mitogen-activated protein kinase pathways in vascular smooth muscle cells. Circ. Res., 1999, 85, 787-795.
136. Sun, R.; Chen, X.; Yang, V. W. Intestinal-enriched Kruppel-like factor (Kruppel-like factor 5) is a positive regulator of cellular proliferation. J. Biol. Chem., 2001, 276, 6897-6900.